US: ABSCF - AB Science S.A

Rentabilität für sechs Monate: -41.85%
Dividendenrendite: 0.00%

Aktionsplan AB Science S.A


Über das Unternehmen AB Science S.A

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France.

weitere details
The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета eur
Сайт https://www.ab-science.com
Цена ао 1.57
Preisänderung pro Tag: 0% (1.57)
Preisänderung pro Woche: 0% (1.57)
Preisänderung pro Monat: 0% (1.57)
Preisänderung über 3 Monate: +96.25% (0.8)
Preisänderung über sechs Monate: -41.85% (2.7)
Preisänderung pro Jahr: -38.43% (2.55)
Preisänderung über 3 Jahre: -86.35% (11.5)
Preisänderung über 5 Jahre: -71.3% (5.47)
Preisänderung seit Jahresbeginn: +76.4% (0.89)

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -38.26 0
Rentabilität Ebitda, % -38.04 0
Rentabilität EPS, % -56.74 0
Gesamt: 0.4

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Alain Moussy MBA Co-Founder, Chairman, President, CEO, MD & Scientific Director
Mr. Laurent Guy MBA Chief Financial Officer
Mr. Christian FASSOTTE Global Chief Medical Officer
Mr. Alexis BERNARD Head of Veterinary Sales
Mr. Harshad KULKARNI Head of Statistics
Dr. Albert Ahn D.V.M. President of USA Operations

Adresse: France, Paris, 3 avenue George V - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.ab-science.com